REMD-477, a human glucagon receptor (GCGR) antibody, reduces daily insulin requirements and improves glycaemic control in people with type 1 diabetes
DIABETES（2017）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined